These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31639544)

  • 1. Extended-spectrum β-lactamase-producing Proteus mirabilis with multidrug resistance isolated from raw chicken in Singapore: Genotypic and phenotypic analysis.
    Guo S; Aung KT; Tay MYF; Seow KLG; Ng LC; Schlundt J
    J Glob Antimicrob Resist; 2019 Dec; 19():252-254. PubMed ID: 31639544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.
    Luzzaro F; Perilli M; Amicosante G; Lombardi G; Belloni R; Zollo A; Bianchi C; Toniolo A
    Int J Antimicrob Agents; 2001 Feb; 17(2):131-5. PubMed ID: 11165117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
    Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
    J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
    Wang JT; Chen PC; Chang SC; Shiau YR; Wang HY; Lai JF; Huang IW; Tan MC; Lauderdale TL;
    BMC Infect Dis; 2014 Sep; 14():486. PubMed ID: 25192738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic and phenotypic profiles of virulence factors and antimicrobial resistance of Proteus mirabilis isolated from chicken carcasses: potential zoonotic risk.
    Sanches MS; Baptista AAS; de Souza M; Menck-Costa MF; Koga VL; Kobayashi RKT; Rocha SPD
    Braz J Microbiol; 2019 Jul; 50(3):685-694. PubMed ID: 31049879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report of bla
    Leulmi Z; Kandouli C; Mihoubi I; Benlabed K; Lezzar A; Rolain JM
    J Glob Antimicrob Resist; 2019 Mar; 16():125-129. PubMed ID: 30217548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    Kanayama A; Iyoda T; Matsuzaki K; Saika T; Ikeda F; Ishii Y; Yamaguchi K; Kobayashi I
    Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine.
    Chen L; Al Laham N; Chavda KD; Mediavilla JR; Jacobs MR; Bonomo RA; Kreiswirth BN
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4305-7. PubMed ID: 25896692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of multidrug-resistant Proteus mirabilis isolated from chicken carcasses.
    Wong MH; Wan HY; Chen S
    Foodborne Pathog Dis; 2013 Feb; 10(2):177-81. PubMed ID: 23351030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
    Protonotariou E; Poulou A; Politi L; Meletis G; Chatzopoulou F; Malousi A; Metallidis S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2020 Aug; 56(2):106060. PubMed ID: 32574790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a modified double-disc synergy test for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-producing proteus mirabilis.
    Khan MK; Thukral SS; Gaind R
    Indian J Med Microbiol; 2008; 26(1):58-61. PubMed ID: 18227600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region.
    Siebor E; Neuwirth C
    J Antimicrob Chemother; 2011 Nov; 66(11):2513-20. PubMed ID: 21846670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
    Rajivgandhi G; Maruthupandy M; Manoharan N
    Microb Pathog; 2018 Aug; 121():123-130. PubMed ID: 29778819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome sequence of a New Delhi metallo-β-lactamase 1-producing Proteus mirabilis isolate SNYG35 from broiler chicken in China.
    Xie X; Zhang J; Wang HN; Lei CW
    J Glob Antimicrob Resist; 2021 Mar; 24():266-269. PubMed ID: 33476836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].
    Treviño M; Navarro D; Barbeito G; Areses P; García-Riestra C; Regueiro BJ
    Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.
    Corvec S; Beyrouthy R; Crémet L; Aubin GG; Robin F; Bonnet R; Reynaud A
    Antimicrob Agents Chemother; 2013 May; 57(5):2410-2. PubMed ID: 23478954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan.
    Kanayama A; Kobayashi I; Shibuya K
    Int J Antimicrob Agents; 2015 Feb; 45(2):113-8. PubMed ID: 25182712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Susceptibility and Molecular Epidemiology of
    Lin MF; Liou ML; Kuo CH; Lin YY; Chen JY; Kuo HY
    Microb Drug Resist; 2019 Nov; 25(9):1338-1346. PubMed ID: 31295061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.